A formulationâenabled preclinical efficacy assessment of a farnesoid X receptor agonist, GW4064, in hamsters and cynomolgus monkeys
Keywords: FXR agonist; efficacy; SEDDS; oral bioavailability; salt form; poorly soluble drug;